Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Johnson & Johnson to continue rolling out across the US – but is it safe?

Published

on

The United States has recommenced the rollout of the Johnson and Johnson coronavirus vaccine, after the jab was halted almost two weeks ago pending an investigation into possible blood clot cases.

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration released a joint statement, revealing that they would still warn of the risk of a potentially fatal side effect involving severe blood clots and low platelets in a fact sheet given to recipients.

Officials from America’s Food and Drug Administration said the decision to recommence the rollout of the Johnson and Johnson jab was effective immediately, making it possible for the vaccine to be accessible again as early as Saturday.

“We are no longer recommending a pause in the use of this vaccine” – CDC Director Rochelle Walensky

Medical watchdogs have determined there is a likely link between the J&J vaccine and blood clotting, ‘based on an in-depth analysis’ but urged the risk remains very low.

America’s latest decision on Johnson and Johnson vaccine follows a similar one made by the European Medicines Agency earlier this week.

The EMA on Tuesday said the benefits of the J&J COVID-19 vaccine outweighed any risks.

The European medical regulator recommended adding a warning about unusual blood clots with low blood platelet counts to the vaccine’s product label, which enabled J&J to resume its rollout across Europe.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Markets brace for pivotal week following renewed US-China trade talks

Global markets brace for US-China trade talks, earnings, and inflation data impacting investor sentiment and central bank outlook.

Published

on

Global markets brace for US-China trade talks, earnings, and inflation data impacting investor sentiment and central bank outlook.


Global markets prepare for a critical week as US–China trade talks, major earnings, and inflation data could shift investor sentiment and central bank expectations.

Kyle Rodda from Capital.com breaks down the key risks and opportunities.

#GlobalMarkets #USChinaTrade #Inflation #EarningsSeason #Investing #FederalReserve #AUD #Tesla #Netflix #MarketUpdate


Download the Ticker app

Continue Reading

News

Global markets steady ahead of CPI

Global equities stay strong near record highs as investors await US CPI data to assess central bank decisions.

Published

on

Global equities stay strong near record highs as investors await US CPI data to assess central bank decisions.


Global equities remain resilient, with Wall Street, Europe, and Asia near record highs as investors eye Friday’s US CPI data to gauge central bank moves.

Market watchers note cautious optimism amid ongoing volatility.

#GlobalMarkets #CPI #WallStreet #Equities #Investing #CentralBanks #RBA #Fed #USMarkets #MarketUpdate


Download the Ticker app

Continue Reading

News

US sanctions Russia’s top oil giants

US sanctions on Rosneft and Lukoil aim to pressure Moscow amid oil price surges; impact depends on enforcement.

Published

on

US sanctions on Rosneft and Lukoil aim to pressure Moscow amid oil price surges; impact depends on enforcement.


The US has imposed new sanctions on Rosneft and Lukoil, aligning with Europe to pressure Moscow amid rising oil prices and global market tensions.

Analysts warn the real impact will hinge on enforcement and international response.

#Russia #USSanctions #Rosneft #Lukoil #OilMarkets #Geopolitics #EnergyCrisis #DonaldTrump #EU #GlobalTrade #Moscow


Download the Ticker app

Continue Reading

Trending Now